Sotalol prolongation of the QTC interval in hypertensive patients
- 1 July 1982
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 32 (1) , 25-32
- https://doi.org/10.1038/clpt.1982.122
Abstract
The effect of oral sotalol on the heart rate-corrected QT interval (QTc) was studied in 33 hypertensive patients. Sotalol given once daily in doses of 160-640 mg prolonged the QTc interval in a concentration-dependent manner by up to 150 ms (P < 0.001) over presotalol levels. The prolongation did not correlate with the initial length of the QTc interval. In 7 patients with sotalol-prolonged QTc interval, the withdrawal of sotalol for 3 days shortened the interval to nearly its original length. The effect of sotalol on PQ and QRS times was minimal. Sotalol seems to differ from other .beta. antagonists in having clear amiodarone-like effects on the action potential of the heart after short- and long-term administration. The measuring of the QTc interval is recommended if high sotalol concentrations are expected, since the risk of cardiac arrhythmias may increase.This publication has 13 references indexed in Scilit:
- Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden deathPublished by Elsevier ,2004
- Sotalol kinetics in renal insufficiencyClinical Pharmacology & Therapeutics, 1981
- Effect of Metoprolol on QTC Intervals after Acute Myocardial InfarctionActa Medica Scandinavica, 1980
- Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiencyEuropean Journal of Clinical Pharmacology, 1980
- AMIODARONE-INDUCED VENTRICULAR-FIBRILLATION1980
- Effect of intravenous propranolol on QT interval. A new method of assessment.Heart, 1980
- Plasma clearance of propranolol and sotalol and hepatic drug‐metabolizing enzyme activityClinical Pharmacology & Therapeutics, 1979
- Sotalol Intoxication, Two Patients with Concentration ‐ Effect RelationshipsActa Pharmacologica et Toxicologica, 1979
- QT time in patients treated with alprenolol or placebo after myocardial infarction.Heart, 1979
- QT interval prolongation as predictor of sudden death in patients with myocardial infarction.Circulation, 1978